Literature DB >> 25040878

Quality of life of patients with 46,XX and 46,XY disorders of sex development.

Rita Cassia Amaral1, Marlene Inacio, Vinicius N Brito, Tania A S S Bachega, Sorahia Domenice, Ivo J P Arnhold, Guiomar Madureira, Larissa Gomes, Elaine M F Costa, Berenice B Mendonca.   

Abstract

Disorders of sex development (DSD) result from abnormalities in the complex process of sex determination and differentiation. An important consideration to guide the assignment of social sex in newborns with ambiguous genitalia is the quality of life (QoL) of these patients in adulthood. The rarity of most DSD conditions makes it difficult to conduct a long-term follow-up of affected patients through adulthood. This review of papers on the QoL of DSD patients evaluated in developing and developed countries by qualitative and quantitative instruments revealed a large spectrum of QoL, ranging from very poor to similar to, or even better than, the normal population. A more adequate QoL was found in patients from tertiary centres, indicating that the medical care of DSD patients should be multidisciplinary and carried out by specialized teams.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25040878     DOI: 10.1111/cen.12561

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

Review 1.  Genetics of Disorders of Sex Development: The DSD-TRN Experience.

Authors:  Emmanuèle C Délot; Jeanette C Papp; David E Sandberg; Eric Vilain
Journal:  Endocrinol Metab Clin North Am       Date:  2017-03-28       Impact factor: 4.741

2.  The influence of psychosocial and sexual wellbeing on quality of life in women with differences of sexual development.

Authors:  Ariane Liedmeier; David Jendryczko; Marion Rapp; Robert Roehle; Ute Thyen; Baudewijntje P C Kreukels
Journal:  Compr Psychoneuroendocrinol       Date:  2021-09-24

Review 3.  Disorders/Differences of Sex Development Presenting in the Newborn With 46,XY Karyotype.

Authors:  Silvano Bertelloni; Nina Tyutyusheva; Margherita Valiani; Franco D'Alberton; Fulvia Baldinotti; Maria Adelaide Caligo; Giampiero I Baroncelli; Diego G Peroni
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

4.  Participation of adults with disorders/differences of sex development (DSD) in the clinical study dsd-LIFE: design, methodology, recruitment, data quality and study population.

Authors:  Robert Röhle; Katharina Gehrmann; Maria Szarras-Czapnik; Hedi Claahsen-van der Grinten; Catherine Pienkowski; Claire Bouvattier; Peggy Cohen-Kettenis; Anna Nordenström; Ute Thyen; Birgit Köhler
Journal:  BMC Endocr Disord       Date:  2017-08-18       Impact factor: 2.763

5.  Identifying the Resource Needs of Young People with Differences of Sex Development.

Authors:  Gina Tonkin-Hill; Chloe Hanna; Roberto Bonelli; Rowena Mortimer; Michele A O'Connell; Sonia R Grover
Journal:  J Clin Med       Date:  2022-07-27       Impact factor: 4.964

6.  A 15-20-year follow-up of mental health, psychosocial functioning and quality of life in a single center sample of individuals with differences in sex development.

Authors:  Anne Waehre; Charlotte Heggeli; Kirsten Hald; Anne Grethe Myhre; Trond Diseth
Journal:  Health Psychol Behav Med       Date:  2022-09-06

7.  Multicentre cross-sectional clinical evaluation study about quality of life in adults with disorders/differences of sex development (DSD) compared to country specific reference populations (dsd-LIFE).

Authors:  Marion Rapp; Esther Mueller-Godeffroy; Peter Lee; Robert Roehle; Baudewijntje P C Kreukels; Birgit Köhler; Anna Nordenström; Claire Bouvattier; Ute Thyen
Journal:  Health Qual Life Outcomes       Date:  2018-04-03       Impact factor: 3.186

Review 8.  Caring for individuals with a difference of sex development (DSD): a Consensus Statement.

Authors:  Martine Cools; Anna Nordenström; Ralitsa Robeva; Joanne Hall; Puck Westerveld; Christa Flück; Birgit Köhler; Marta Berra; Alexander Springer; Katinka Schweizer; Vickie Pasterski
Journal:  Nat Rev Endocrinol       Date:  2018-07       Impact factor: 43.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.